certainly been an interesting couple of days, especially after i posted pretty much the day before saying i cant see a problem!
We were looking very rosy due to upcoming annoucements such phase 1a beginning soon and u.s. listing this year. Large jumps in sp as we have had are usually due to imment value enchancing annoucements.
people want to make fast coin afterall. seems it wasnt fast enough!
Now i remeber someone on here was saying they believed it would be beneficial to speed up progress of construction and take on more debt. sort of dont be late to the party.
It appears the advisory lot were thinking along similar lines and have convinced the board of as i belive daze put it; a risker path, now yes having troubles when in the red alot more money and dilution is at stake as what was previously with a conservative 3 phases, however we must rememeber what is owned by abr and what progress has already been made.
All permits, Plus extended mine life and higher grades. Seems like making utterly sure a world class producer is being realised. The decision would not have been taken lightly and certainly not with the knowlege i beleive the board had prior. All was going well. An annoucement such as this and at this time is going to raise eyebrows. Any stock with annoucements due rises up in excitement. those who wanted a quick buck didnt want to wait as they never do. The marketnproves it time and time again. My opinion, not anyone who beleives they can do better elsewhere.
So, ill put my neck out and say have a look at what happens in 12 months. Think ill be happy personally.
The ego needs to make way for the most appropriate course of action when it comes to an end goal.
I was a bit shortsighted to think abr was immune to this.
- Forums
- ASX - By Stock
- ABR
- Ann: ABR Defers Phase 1A of Fort Cady Mine to enhance US Listing
Ann: ABR Defers Phase 1A of Fort Cady Mine to enhance US Listing, page-152
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ABR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online